Science Explorer Back to mapMap
Discussion
Company · Lianyun · China

Hansoh Pharma (China)

Research works
57
▲ 214% vs 2018-21
Citations
261
4.6 per fractional work
Top-10% rate
4.1%
all institutions 10.0%
Open access
33%
world 40%
International
12%
world 18%

Not ranked overall: Hansoh Pharma (China) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Hansoh Pharma (China) work in?

In 2022-now, 53% of research at Hansoh Pharma (China) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (18%), Chemistry (11%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 13 fractional works · 52.6% of its workMedicine: 12 fractional works · 51.8% of its workPulmonary and Respiratory Medicine: 3 fractional works · 14.3% of its workOncology: 3 fractional works · 11.4% of its workHematology: 1 fractional works · 5.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 4.5% of its workEpidemiology: 1 fractional works · 2.7% of its workNephrology: 1 fractional works · 2.6% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.4% of its workGenetics: 0 fractional works · 2.1% of its workInfectious Diseases: 0 fractional works · 1.3% of its workSurgery: 0 fractional works · 1.2% of its workBiochemistry: 0 fractional works · 0.7% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workHealth Informatics: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.5% of its workOral Surgery: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.3% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workLife Sciences: 6 fractional works · 25.5% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 17.8% of its workMolecular Biology: 3 fractional works · 13.5% of its workCancer Research: 1 fractional works · 2.3% of its workGenetics: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.3% of its workBiophysics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 4.5% of its workPharmaceutical Science: 1 fractional works · 4.0% of its workPharmacology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 1.6% of its workPlant Science: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 0.9% of its workImmunology: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 0 fractional works · 0.7% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 20.8% of its workChemistry: 3 fractional works · 11.4% of its workOrganic Chemistry: 2 fractional works · 9.2% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workInorganic Chemistry: 0 fractional works · 0.7% of its workSpectroscopy: 0 fractional works · 0.6% of its workEngineering: 1 fractional works · 5.7% of its workComputational Mechanics: 0 fractional works · 1.8% of its workMechanical Engineering: 0 fractional works · 1.6% of its workBiomedical Engineering: 0 fractional works · 1.6% of its workBuilding and Construction: 0 fractional works · 0.7% of its workMathematics: 0 fractional works · 1.6% of its workStatistics and Probability: 0 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 1.0% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.5% of its workMaterials Chemistry: 0 fractional works · 0.5% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workEnergy: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.9% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKHansoh Pharma(China)24fractional works, 2022-now
Life Sciences25%Physical Sciences21%Health Sciences53%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1251.8%
    2. Dentistry00.5%
    3. Health Professions00.3%
    1. Biochemistry, Genetics and Molecular Biology417.8%
    2. Pharmacology, Toxicology and Pharmaceutics14.5%
    3. Agricultural and Biological Sciences01.6%
    4. Immunology and Microbiology00.9%
    5. Neuroscience00.7%
    1. Chemistry311.4%
    2. Engineering15.7%
    3. Mathematics01.6%
    4. Environmental Science01.0%
    5. Materials Science00.5%
    6. Computer Science00.3%
    7. Energy00.2%
    1. Economics, Econometrics and Finance00.9%
    2. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.34× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.34× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 0.88× its world share, 0 worksImmunology and Micro…Neuroscience: 0.45× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 12.68× its world share, 1 worksPharmacology, Toxico…Chemistry: 7.29× its world share, 3 worksChemistryComputer Science: 0.03× its world share, 0 worksComputer ScienceEnergy: 0.22× its world share, 0 worksEnergyEngineering: 0.38× its world share, 1 worksEngineeringEnvironmental Science: 0.21× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.13× its world share, 0 worksMaterials ScienceMathematics: 1.38× its world share, 0 worksMathematicsDentistry: 0.96× its world share, 0 worksDentistryHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 2.69× its world share, 12 worksMedicineEconomics, Econometrics and Finance: 0.44× its world share, 0 worksEconomics, Econometr…Psychology: 0.06× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 12.7×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics12.68×1 works
  2. Chemistry7.29×3 works
  3. Biochemistry, Genetics and Molecular Biology3.34×4 works
  4. Medicine2.69×12 works
  5. Mathematics1.38×0 works
  6. Dentistry0.96×0 works
  7. Immunology and Microbiology0.88×0 works
  8. Neuroscience0.45×0 works
  9. Economics, Econometrics and Finance0.44×0 works
  10. Engineering0.38×1 works
  11. Agricultural and Biological Sciences0.34×0 works
  12. Energy0.22×0 works
  13. Environmental Science0.21×0 works
  14. Materials Science0.13×0 works
  15. Health Professions0.13×0 works
  16. Psychology0.06×0 works
  17. Computer Science0.03×0 works

Who are the top researchers at Hansoh Pharma (China)?

Ranked on the quality score, Yunfan Li, Jeffrey Jasper and Wang Chun-ling lead among researchers whose main affiliation is Hansoh Pharma (China).

  1. 1 Yunfan Li China · #1,943,979 worldwide 246 citations · 40 works
  2. 2 Jeffrey Jasper China · #4,302,311 worldwide 230 citations · 15 works
  3. 3 Wang Chun-ling China · #4,898,698 worldwide 2 citations · 22 works
All ranked researchers at Hansoh Pharma (China)

What are the most cited papers from Hansoh Pharma (China)?

The most cited paper from Hansoh Pharma (China) is "AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations" (Shun Lü et al., 2022), with 302 citations. Next come "Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial" (152) and "MT1‐MMP‐Activated Liposomes to Improve Tumor Blood Perfusion and Drug Delivery for Enhanced Pancreatic Cancer Therapy" (66).

All 61 most cited papers, with filters and sorting

Which keywords describe research at Hansoh Pharma (China)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Clinical Trials, Chemotherapy, Genomic Profiling, ALK Inhibitors, EGFR Mutations, Chronic Kidney Disease and Monoclonal Antibody.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Targeted Therapy3▲ 54×3 topics
  2. Chemotherapy3▲ 15×8 topics
  3. Clinical Trials3▲ 17×5 topics
  4. Genomic Profiling2▲ 80×2 topics
  5. ALK Inhibitors2▲ 131×1 topic
  6. EGFR Mutations2▲ 131×1 topic
  7. Cardiovascular Disease2▲ 6.1×8 topics
  8. Chronic Kidney Disease2▲ 27×5 topics
  9. Monoclonal Antibody2▲ 123×2 topics
  10. Heart Failure2▲ 14×3 topics
  11. Glycosylation1▲ 46×2 topics
  12. Prognostic Factors1▲ 11×4 topics
  13. Biomarkers1▲ 6.8×7 topics
  14. Monoclonal Antibodies1▲ 50×3 topics
  15. Cell Culture1▲ 37×2 topics
  16. Epidemiology1◆ 1.07×9 topics
  17. Mammalian Cells1▲ 183×1 topic
  18. Recombinant Protein1▲ 183×1 topic
  19. Synthesis1▲ 11×4 topics

Which research topics does Hansoh Pharma (China) publish most on?

By volume in 2022-now: Lung Cancer Treatments and Mutations, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability and Erythropoietin and Anemia Treatment.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  3. 3 Protein purification and stability Molecular Biology 1 works
  4. 4 Erythropoietin and Anemia Treatment Hematology 1 works
  5. 5 HER2/EGFR in Cancer Research Oncology 1 works
  6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  7. 7 Drug Solubulity and Delivery Systems Pharmaceutical Science 1 works
  8. 8 Lung Cancer Research Studies Oncology 0 works
  9. 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Protein Degradation and Inhibitors Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.1%not open66.9%

World: 40% of research is openly available.

with international co-authors11.6%domestic only88.4%

World: 18% is written across borders.

How has Hansoh Pharma (China)'s research output changed?

Output in 2022-2025 was 214% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Hansoh Pharma (China) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00010%0.00020%0.00030%Hansoh Pharma (China)0.000041% in 202520102020

Fractional works of Hansoh Pharma (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lianyun

All research institutions in Lianyun

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Hansoh Pharma (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.